Key result
Permanent pacemaker implantation linked to thromboembolic events, present in ~1.7% of pulmonary embolism patients.
Why the study?
Studies have addressed the potential risk of distal pulmonary vascular involvement with pacemakers, but none has conclusively proven this hypothesis, justifying prevention strategies.
The review highlights the potential risk of thromboembolic events and chronic thromboembolic pulmonary hypertension following permanent pacemaker implantation, emphasizing the need for preventive strategies.
No takes yet. Share an insight, caveat, or question.
Association with thromboembolism in pacemaker patients merits clinical awareness; leaves open causal mechanisms and preventive strategies pending higher-level evidence.
Yoncheva et al. (2020) conducted a review in Pulmonary Hypertension and Pulmonary Embolism. Permanent pacemaker implantation was evaluated. Permanent pacemaker implantation is associated with thromboembolic events, with 1.7% of pulmonary embolism patients having an implantable device compared to 0.16-0.47% of the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: